- Morpholino-driven blockade of Dkk-1 in osteosarcoma inhibits bone damage and tumour expansion by multiple mechanisms (2022, British Journal of Cancer)
- A Scalable System for Generation of Mesenchymal Stem Cells Derived from Induced Pluripotent Cells Employing Bioreactors and Degradable Microcarriers (2021, Stem Cells Translational Medicine)
- Characterization of a pluripotent stem cell-derived matrix with powerful osteoregenerative capabilities (2020, Nature Communications)
- How stem cell composition in bone marrow aspirate relates to clinical outcomes when used for cervical spine fusion (2018, PLoS One)
- Widespread changes in transcriptome profile of human mesenchymal stem cells induced by two-dimensional nanosilicates (2018, PNAS)
- Rapid Osteogenic Enhancement of Stem Cells in Human Bone Marrow Using a Glycogen‐Synthease‐Kinase‐3‐Beta Inhibitor Improves Osteogenic Efficacy In Vitro and In Vivo (2018, Stem Cells Transnational Medicine)
- The effects of the Er:YAG laser on trabecular bone micro-architecture: Comparison with conventional dental drilling by micro-computed tomographic and histological techniques (2017, F1000 Research)
- Time-lapse microscopic observation of non-dividing cells in cultured human osteosarcoma MG-63 cell line (2018, Cell Cycle)
- In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study (2017, Stem Cell Research & Therapy)
- Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model (2017, Stem Cell Research & Therapy)
- Comparison of the anti-inflammatory effects of induced pluripotent stem cell-derived and bone marrow-derived mesenchymal stromal cells in a murine model of corneal injury (2017, Cytotherapy)
- Theobromine upregulates osteogenesis by human mesenchymal stem cells in vitro and accelerates bone development in rats (2017, Calcified Tissue International)
- An allograft generated from adult stem cells and their secreted products efficiently fuses vertebrae in immunocompromised athymic rats and inhibits local immune responses (2017, The Spine Journal)
- iPS-derived MSCs from an expandable bank to deliver a prodrug-converting enzyme that limits growth and metastases of human breast cancers (2017, Cell Death Discovery)
- Scalable Production of a Multifunctional Protein (TSG-6) That Aggregates with Itself and the CHO Cells That Synthesize It (2016, PLoS One)
- A Simple Critical-sized Femoral Defect Model in Mice (2015, Journal of Visualized Experiments)
- MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs (2015, PNAS)
- Bone regeneration with osteogenically enhanced mesenchymal stem cells and their extracellular matrix proteins (2015, Journal of Bone and Mineral Research)
- An unexpected role for a Wnt-inhibitor: Dickkopf-1 triggers a novel cancer survival mechanism through modulation of aldehyde-dehydrogenase-1 activity (2014, Cell Death Discovery)
- Short Term Culture of Human Mesenchymal Stem Cells with Commercial Osteoconductive Carriers Provides Unique Insights into Biocompatibility (2013, Journal of Clinical Medicine)
- Human Mesenchymal Stem Cell–Derived Matrices for Enhanced Osteoregeneration (2012, Science Transnational Medicine)
- Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma–induced bone disease in a novel murine plasmacytoma xenograft model (2011, Blood)
- Sox11 Is Expressed in Early Progenitor Human Multipotent Stromal Cells and Decreases with Extensive Expansion of the Cells (2010, Tissue Engineering Part A)
- Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy (2010, PNAS)
- CD133 Identifies a Human Bone Marrow Stem/Progenitor Cell Sub-population With a Repertoire of Secreted Factors That Protect Against Stroke (2009, Molecular Therapy)
- Multipotent Stromal Cells (MSCs) are Activated to Reduce Apoptosis in Part by Upregulation and Secretion of Stanniocalcin-1 (STC-1) (2009, Stem Cells)
- Leukemia Inhibitory Factor Secretion is a Predictor and Indicator of Early Progenitor Status in Adult Bone Marrow Stromal Cells (2009, Tissue Engineering Part A)
- The CD34-like protein PODXL and α6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice (2008, Blood)